Determinants of Metabolic Syndrome and Type 2 Diabetes in the Absence of Obesity: The Jackson Heart Study

被引:2
|
作者
Mongraw-Chaffin, Morgana [1 ]
Saldana, Santiago [2 ]
Carnethon, Mercedes R. [3 ]
Chen, Haiying [2 ]
Effoe, Valery [4 ]
Golden, Sherita Hill [5 ]
Joseph, Joshua [6 ]
Kalyani, Rita R. [5 ]
Bertoni, Alain G. [1 ]
机构
[1] Wake Forest Sch Med, Dept Epidemiol & Prevent, Med Ctr Blvd, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27157 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[4] Morehouse Sch Med, Div Cardiol, Atlanta, GA 30310 USA
[5] Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[6] Ohio State Univ, Wexner Med Ctr, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA
关键词
type; 2; diabetes; metabolic syndrome; visceral fat normal weight; African American; BODY-MASS INDEX; CARDIOMETABOLIC RISK-FACTORS; SUBCUTANEOUS ADIPOSE-TISSUE; VISCERAL FAT; CARDIOVASCULAR-DISEASE; NORMAL-WEIGHT; AFRICAN-AMERICANS; HEALTHY OBESITY; CONSEQUENCES; ACCUMULATION;
D O I
10.1210/jendso/bvac059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Multiple studies suggest that adults who were normal weight at diabetes diagnosis are at higher risk for all-cause mortality than those who had overweight or obesity at diagnosis. Objective: While obesity is a known risk factor for cardiometabolic disease, differences in body fat distribution in those without obesity are understudied, especially in African Americans. Methods: In 1005 participants of the Jackson Heart Study, without cardiovascular disease at baseline, we used logistic regression to investigate the longitudinal association of body fat distribution by CT scan with metabolic syndrome (MetS) or type 2 diabetes (T2D). We used the harmonized International Diabetes Federation criteria to define MetS. We included only normal weight or overweight participants (BMI: 18.5 to < 30.0 kg/m(2)). We created separate models for MetS and T2D adjusted for a standard set of covariates. We excluded participants with prevalent MetS or T2D, respectively in sensitivity. Results: Higher visceral fat, subcutaneous fat, BMI, and insulin resistance (HOMA-IR) were significantly associated with MetS and T2D after adjustment. Visceral fat was strongly associated with both outcomes (MetS OR = 2.07 [1.66-2.68]; T2D OR = 1.51 [1.21-1.88]), and the association for MetS persisted in the normal weight only group. Estimates were robust to sensitivity analysis and were only modestly mediated by insulin resistance. Physical activity was not associated with MetS or T2D. Conclusion: Visceral fat is strongly associated with developing MetS, even in normal weight individuals, suggesting that excess visceral fat plays a role in cardiometabolic risk beyond that of overall adiposity and obesity in African Americans.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Metformin for the prevention of androgen deprivation induced metabolic syndrome, obesity and type 2 diabetes
    Cohen, Paul
    MEDICAL HYPOTHESES, 2009, 72 (02) : 227 - 228
  • [42] Obesity, Type 2 Diabetes, and the Metabolic Syndrome Pathophysiologic Relationships and Guidelines for Surgical Intervention
    Genser, Laurent
    Mariolo, James Rossario Casella
    Castagneto-Gissey, Lidia
    Panagiotopoulos, Spyros
    Rubino, Francesco
    SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (04) : 681 - +
  • [43] Milk and dairy products in the prevention and therapy of obesity, type 2 diabetes and metabolic syndrome
    Jaffiol, Claude
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2008, 192 (04): : 749 - 758
  • [44] The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2
    Saad, Farid
    Gooren, Louis J.
    JOURNAL OF OBESITY, 2011, 2011
  • [45] Relationship between Childhood Obesity and Late Development of Metabolic Syndrome and Type 2 Diabetes
    Melendez Araujo, M.
    de Matos Arruda, S. L.
    Silva Oliveira, M. L.
    Franca, F.
    Barros, R. A. V.
    Medeiros Santos, R.
    Cubas Rolim, E.
    Daher Milhomem, P.
    Quirino de Sousa, K. P.
    OBESITY SURGERY, 2011, 21 (08) : 1077 - 1077
  • [46] A Modified Sleeve Gastrectomy for the Treatment of Diabetes Mellitus Type 2 and Metabolic Syndrome in Obesity
    Pirolla, E. H.
    Jureidini, R.
    Caravatto, P.
    Barbosa, M. L.
    OBESITY SURGERY, 2011, 21 (08) : 1065 - 1065
  • [47] Diet-Induced Swine Model with Obesity/Leptin Resistance for the Study of Metabolic Syndrome and Type 2 Diabetes
    Torres-Rovira, L.
    Astiz, S.
    Caro, A.
    Lopez-Bote, C.
    Ovilo, C.
    Pallares, P.
    Perez-Solana, M. L.
    Sanchez-Sanchez, R.
    Gonzalez-Bulnes, A.
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [48] Relations Between Subclinical Disease Markers and Type 2 Diabetes, Metabolic Syndrome, and Incident Cardiovascular Disease: The Jackson Heart Study (vol 38, pg 1082, 2015)
    Xanthakis, Vanessa
    Sung, Jung Hye
    Samdarshi, Tandaw E.
    Hill, Alethea N.
    Musani, Solomon K.
    Sims, Mario
    Gharaibeh, Kamel A.
    Liebson, Philip R.
    Taylor, Herman A.
    Vasan, Ramachandran S.
    Fox, Ervin R.
    DIABETES CARE, 2021, 44 (06) : 1455 - 1455
  • [49] Glucose, Obesity, Metabolic Syndrome, and Diabetes Relevance to Incidence of Heart Failure
    Horwich, Tamara B.
    Fonarow, Gregg C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (04) : 283 - 293
  • [50] Obesity in Adults Is Associated With Reduced Lung Function in Metabolic Syndrome and Diabetes The Strong Heart Study
    Yeh, Fawn
    Dixon, Anne E.
    Marion, Susan
    Schaefer, Carl
    Zhang, Ying
    Best, Lyle G.
    Calhoun, Darren
    Rhoades, Everett R.
    Lee, Elisa T.
    DIABETES CARE, 2011, 34 (10) : 2306 - 2313